THE IMPACT OF UNDERUSING LIPID-LOWERING MEDICATIONS ON THE RISK OF HEART ATTACK AND HOSPITALIZATIONS IN UNITED STATES ELDERLY POPULATION
Author(s)
Cheng W
University of Southern California, Los Angeles, CA, USA
OBJECTIVES: In the United States, one in ten cardiovascular events was directly linked to nonadherence in recent years. Our study aimed to estimate the prevalence of underusing lipid medications in elderly and the impact of underuse on the risk of heart attack events and hospitalizations. METHODS: We examined the underuse of lipid medications by analyzing Health and Retirement Study (HRS) data from year 2006 to 2012, among the cohort aged 51 years and older. Our sample included the respondents expected to obtain the greatest cardiovascular disease risk reduction benefit from lipid medications. The respondents reported not using any lipid medications for the last 2 years were defined as underuse group. Cox proportional hazards model was conducted to examine the impact of underuse on hazards of heart attack events. Poisson regression model was built to evaluate the association between underuse and total number of hospitalization stays. RESULTS: The study cohort included 10,854 respondents with 57.8% of them underused lipid medications. The average time to first heart attack event were 2.4-years in underuse group and 4.2-years in non-underuse group. The average numbers of hospitalization stays were 6.4 in underuse and 4.5 in non-underuse group during the follow-up period. The Hazard Ratio (HR) of the first heart attack was 1.32 (95% CI: 1.03 - 1.61) in underuse versus non-underuse group. The lipid medication underuse was significantly associated with higher number of hospitalization stays (β-coefficient = 0.52 ; 95% CI 0.11 - 0.93). The HR and coefficient estimates of Poisson model remained significant after adjusting respondents’ baseline characteristics and health status. CONCLUSIONS: Over half of the U.S. elderly at risk had the problem of underusing lipid-lowering medications. The underuse of lipid medications was significantly associated with higher risk of heart attack events and higher numbers of hospitalization stays, which could lead to great health care burdens in the U.S. society.
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PCV22
Topic
Clinical Outcomes, Epidemiology & Public Health
Topic Subcategory
Comparative Effectiveness or Efficacy, Safety & Pharmacoepidemiology
Disease
Cardiovascular Disorders